The Food and Drug Administration on Monday ordered 23andMe to stop sales of its $99 home genetic testing kits, saying the Google-backed company has not proven the validity of its product.
 The upside of these at-home genetic testing kits and 23andMe isn't the only company that sells them is that they've generated a lot of buzz about genetics, Nagy says.
 Hartmann says he now believes he will not get limb-girdle muscular dystrophy, although he says there is a risk he could pass the genetic mutations onto his kids.
 It can also be misleading.
 